ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Sommers Schwartz Serves Dr. Hardik Shah With Intent to Sue for Medical Malpractice Involving Former State Representative Terence Mekoski

Sommers Medmal 1

Detroit, Michigan – Michigan-based law firm Sommers Schwartz has served Dr. Hardik Shah with intent to sue for medical malpractice after former state representative Terence Mekoski developed bilateral fungal knee infections under Dr. Shah’s care, leading to two-stage bilateral knee replacement surgeries. The claim also includes vicarious liability against the Institute of Neuromuscular Medicine, PLC, for Dr. Shah’s conduct in treating Mr. Mekoski.

Mr. Mekoski first contacted Dr. Shah seeking evaluation and treatment for bilateral knee pain on January 1, 2022. The encounter took place at Dr. Shah’s home, and it is unclear what assessments or findings were made. Dr. Shah evaluated Mr. Mekoski and reached several assessments, including osteoarthritis in both knees.

Over the following months, Dr. Shah performed several injections into Mr. Mekoski’s knees and neck and shoulders, with minimal documentation of the amounts injected. Despite Mr. Mekoski’s ongoing complaints of knee pain, Dr. Shah did not administer the required second injection of Hymovis, a drug used to treat osteoarthritis.

On May 28, 2022, Mr. Mekoski visited the Emergency Department at Beaumont Hospital in Royal Oak, reporting acute knee pain and swelling. The Emergency Department physician noted bilateral joint effusions, and X-rays obtained showed significant degenerative changes in both knees. An orthopedic consult recommended diagnostic aspiration for possible septic joints, which revealed a fungal Candida species.

Mr. Mekoski was hospitalized at the University of Michigan Medical Center for further treatment of bilateral knee pain and fungal infections and underwent multiple irrigations, debridements, and drainage procedures. Eventually, he needed to undergo bilateral two-stage total knee replacements.

The claim against Dr. Shah includes several allegations of substandard medical care, including failure to conduct standard-of-care physical assessments, failure to follow standard protocols and procedures with respect to knee injections, and failure to follow standard sterility practices.

Terence Mekoski’s wife, Anna Mekoski, has also suffered severe loss of consortium as a direct and proximate result of Dr. Shah’s negligence and malpractice.

“While Dr. Shah has claimed one of the solutions he used to inject patients’ knees must have been contaminated before he purchased the product, thus far, we have not been informed by any governmental agency that has investigated this matter that any solutions used in the injection process were contaminated before arriving at Dr. Shah’s offices,” according to Robert Sickels, the attorney handling the matter for Mr. and Mrs. Mekoski. Mr. Sickels further stated: “Therefore, we believe it was the lack of appropriate sterility practices that was a cause of the fungal infections that Mr. Mekoski developed.”

Sommers Schwartz is committed to seeking justice for its clients and holding medical professionals accountable for their negligence. The law firm is prepared to fight for the rights of those who have suffered harm due to medical malpractice.

The case is scheduled to be filed in the Wayne County Circuit Court following the required 6 month notice period.



Sommers Schwartz is a powerhouse litigation firm made up of experienced personal injury lawyers, medical malpractice attorneys, commercial and business law attorneys, and employee rights lawyers fighting for unpaid wages and overtime. The law firm serves clients across the country from its offices in Michigan and California.

Sommers Schwartz, P.C.
1 Towne Square #1700 Southfield, MI 48076
(248) 355-0300
https://www.sommerspc.com/
Press Contact : Media Contact

Distributed by Law Firm Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.